- Home
- EPRX vs UFG Comparison
EPRX vs UFG Comparison
Compare EPRX & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- UFG
- Stock Information
- Founded
- EPRX 2011
- UFG 2021
- Country
- EPRX Canada
- UFG Singapore
- Employees
- EPRX N/A
- UFG N/A
- Industry
- EPRX
- UFG Oil Refining/Marketing
- Sector
- EPRX
- UFG Energy
- Exchange
- EPRX NYSE
- UFG Nasdaq
- Market Cap
- EPRX 130.0M
- UFG 136.4M
- IPO Year
- EPRX N/A
- UFG 2025
- Fundamental
- Price
- EPRX $3.28
- UFG $5.45
- Analyst Decision
- EPRX Strong Buy
- UFG
- Analyst Count
- EPRX 1
- UFG 0
- Target Price
- EPRX $9.00
- UFG N/A
- AVG Volume (30 Days)
- EPRX 11.9K
- UFG 428.0K
- Earning Date
- EPRX 05-07-2025
- UFG 01-01-0001
- Dividend Yield
- EPRX N/A
- UFG N/A
- EPS Growth
- EPRX N/A
- UFG N/A
- EPS
- EPRX N/A
- UFG 0.02
- Revenue
- EPRX N/A
- UFG $130,669,391.00
- Revenue This Year
- EPRX N/A
- UFG N/A
- Revenue Next Year
- EPRX N/A
- UFG N/A
- P/E Ratio
- EPRX N/A
- UFG $289.31
- Revenue Growth
- EPRX N/A
- UFG 129.69
- 52 Week Low
- EPRX $2.20
- UFG $3.50
- 52 Week High
- EPRX $4.48
- UFG $5.73
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- UFG N/A
- Support Level
- EPRX N/A
- UFG N/A
- Resistance Level
- EPRX N/A
- UFG N/A
- Average True Range (ATR)
- EPRX 0.00
- UFG 0.00
- MACD
- EPRX 0.00
- UFG 0.00
- Stochastic Oscillator
- EPRX 0.00
- UFG 0.00
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.